Related Experiment Video
Updated: Aug 29, 2025

Preparation of Cell-lines for Conditional Knockdown of Gene Expression and Measurement of the Knockdown Effects on E4orf4-Induced Cell Death
Published on: October 21, 2012
Assessment of transcription inhibition as a characteristic of immunogenic cell death
Giulia Cerrato1, Juliette Humeau2, Allan Sauvat2
1Equipe labellisée par la Ligue contre le cancer, Université de Paris, Sorbonne Université, INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France; Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France; Université Paris Sud, Paris Saclay, Faculty of Medicine, Kremlin Bicêtre, Paris, France.
Abstract:
Anticancer drugs that suppress DNA-to-RNA transcription are particularly efficient in stimulating immunogenic cell death and hence eradicate malignant cells in a way that they will ignite an antitumor immune response. This is therapeutically relevant as it allows treatment response to last beyond drug discontinuation. For this reason, it is important to measure transcription inhibition in a precise fashion. Here, we detail two complementary assays for the assessment of transcription inhibition, one that detects the physical separation of fibrillarin and nucleolin by two-color immunofluorescence and another that measures the diminution of incorporated 5-ethynyl uridine (EU) into RNA, as revealed by click chemistry and the per-cell-intensity of a fluorescent signal.
Insights
Anticancer drugs inhibiting DNA-to-RNA transcription effectively trigger antitumor immune responses by stimulating immunogenic cell death. Precise measurement of transcription inhibition is crucial for this therapeutic approach.
Area of Science:
- Molecular Biology
- Immunology
- Pharmacology
Background:
- Anticancer drugs suppressing DNA-to-RNA transcription are effective in stimulating immunogenic cell death.
- This mechanism eradicates malignant cells and ignites an antitumor immune response, leading to lasting therapeutic effects.
- Precise measurement of transcription inhibition is essential for optimizing this treatment strategy.
Purpose of the Study:
- To detail two complementary assays for accurately assessing transcription inhibition.
- To provide reliable methods for quantifying the impact of anticancer drugs on RNA transcription.
Main Methods:
- Two-color immunofluorescence assay to detect the physical separation of fibrillarin and nucleolin.
- Click chemistry assay to measure the diminution of incorporated 5-ethynyl uridine (EU) into RNA, assessing per-cell fluorescence intensity.
Main Results:
- The study presents two validated assays for measuring transcription inhibition.
- These methods allow for precise quantification of drug-induced transcription suppression.
Conclusions:
- Accurate assessment of transcription inhibition is vital for anticancer therapies that leverage immunogenic cell death.
- The described assays provide valuable tools for evaluating drug efficacy and optimizing treatment strategies.
More Related Videos
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Extrinsic Apoptotic Pathway
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...

